Taro Pharmaceutical Industries .(TARO) - 2024 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____ TARO PROVIDES RESULTS FOR THE QUARTER ENDED JUNE 30, 2023 Hawthorne, NY, July 26, 2023 - Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today p ...